尤的高调作风是FBI一项不同寻常的行动的一部分,该行动的目的是突出美国仓促寻求破解人类基因组秘密的风险。作为FBI生物对策部门一位负责监管的特工,尤警告称,美国没有保护用来制造有利可图的新药的基因组数据,而这些数据可能还被用来开发可怕的生化武器。
“We don’t know how much bio data has left our shores,” he says. “Our concept for biological security needs to be broadened.”
“我们不知道有多少生物数据流到了国外,”他表示,“我们对生物学安全的概念需要扩大。”
That has led him to focus on China, which the veteran lawman says is gaining access to US genomic data — the biological software that governs human organisms. In recent years, Chinese investors have purchased stakes in, or partnered with, US biomedical companies that specialise in genomics. At the same time, state-sponsored hackers believed to be Chinese have penetrated the laboratories, health insurers and hospitals where other valuable patient records reside. Mr You suggests stricter controls might be needed on what sort of health data can be transferred overseas — to China and elsewhere.
这让他关注中国,这位经验丰富的执法者表示,中国正获取美国基因组数据,即管理人体组织的生物软件。最近几年,中国投资者购入专门研究基因组的美国生物医学公司的股权或与它们合作。同时,据信为中国人的、由政府资助的黑客潜入了存放其他重要患者记录的实验室、健康保险公司和医院。尤认为,在哪些健康数据可以转移到海外(中国和其他国家)方面,可能需要加强控制。
【大国角力的新领域:基因数据】相关文章:
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15